# Step 17F S3 source and feasibility audit

## Scope

- GSE123100 is audited as the planned cross-tissue stiffness dose-response source.
- GSE276045 is audited as the planned WI-38 stiffness-by-proliferation confounding cross-check.
- Only official GEO metadata and supplementary-file listings were read; no expression matrix or large raw file was downloaded.
- Any passing decision authorizes the next targeted matrix audit only; it does not establish fascia specificity or causality.

## Source decisions

### GSE123100

- Role: S3_primary_stiffness_dose_response.
- Samples: 19.
- Stiffness resolved fraction: 0.5789; inferred levels/labels: 13.
- Cell-model summary: trabecular-meshwork-like.
- WI-38 fraction: 0; proliferation resolved fraction: 0.
- Processed-file candidates listed: 4.
- Decision: **PARTIAL_PROCEED_TO_MANUAL_STIFFNESS_REVIEW**.

### GSE276045

- Role: S3_WI38_stiffness_x_proliferation_cross_check.
- Samples: 178.
- Stiffness resolved fraction: 0.7472; inferred levels/labels: 4.
- Cell-model summary: WI-38.
- WI-38 fraction: 1; proliferation resolved fraction: 0.
- Processed-file candidates listed: 1.
- Decision: **PARTIAL_PROCEED_TO_MANUAL_WI38_REVIEW**.

## S3 interpretation boundary

- GSE123100, if advanced, tests the form of a stiffness-related response across tissues; it is not fascia-direct validation.
- GSE276045, if advanced, tests whether a stiffness direction is reproducible across proliferation strata; if proliferation labels are not identifiable, the result remains descriptive.
- A dose-response or cross-check result cannot by itself prove a universal mechanosensitivity mechanism, cell-intrinsic causality, or pain relevance.
- GWAS remains optional and is not required for the S3 computational strengthening branch.

## Material Passport

- Inputs: official NCBI GEO metadata records for GSE123100 and GSE276045.
- Transformation: metadata flattening, stiffness/cell-state keyword audit, biological-unit and batch-field inventory, and supplementary-file classification.
- New large data downloaded: none.
- Next step: only sources with a passing or partial feasibility decision proceed to a targeted processed-matrix audit.
